Biopol Chemicals Limited (NSE:BIOPOL)
India flag India · Delayed Price · Currency is INR
101.95
-2.70 (-2.58%)
At close: Jul 31, 2026

Biopol Chemicals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Revenue
813.72813.72491.28174.33
Revenue Growth
-65.63%181.82%-
Gross Profit
182.71182.7188.4227.91
Operating Income
135.79135.7964.6918.38
Net Income
89.7489.7443.312.81
Earnings Per Share
10.8310.835.47-
EPS Growth
-97.99%--

Revenue by Geography

Fiscal YearFY 2025FY 2024
Period EndingMar '25 Mar '24
India
454.38238.02
Bangladesh
36.9116.68
Total
491.28254.7

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Cash & Investments
5.185.1811.480.82
Total Debt
84.6584.6576.8535.77
Net Cash (Debt)
-79.47-79.47-65.37-34.94
Net Cash Growth
----
Net Cash Per Share
-9.59-9.59-8.26-

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Operating Cash Flow
-127.66-127.66-23.37-88.72
Capital Expenditures
-142-142-0.25-0.71
Free Cash Flow
-269.66-269.66-23.61-89.43
Free Cash Flow Growth
----

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Gross Margin
22.45%22.45%18.00%16.01%
Operating Margin
16.69%16.69%13.17%10.54%
Pretax Margin
14.82%14.82%11.81%9.82%
Profit Margin
11.03%11.03%8.81%7.35%
FCF Margin
-33.14%-33.14%-4.81%-51.30%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024
Period EndingAug '26 Mar '26 Mar '25 Mar '24
PE Ratio
9.4111.69--
PS Ratio
1.351.29--